Literature DB >> 18579275

Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease.

Valéria S Fernandes1, Alessandra M Ribeiro, Thieza G Melo, Monique Godinho, Flavio F Barbosa, Danielle S Medeiros, Hermany Munguba, Regina H Silva.   

Abstract

We have recently verified that the monoamine-depleting drug reserpine--at doses that do not modify motor function--impairs memory in a rodent model of aversive discrimination. In this study, the effects of reserpine (0.1-0.5 mg/kg) on the performance of rats in object recognition, spatial working memory (spontaneous alternation) and emotional memory (contextual freezing conditioning) tasks were investigated. While object recognition and spontaneous alternation behavior were not affected by reserpine treatment, contextual fear conditioning was impaired. Together with previous studies, these results suggest that low doses of reserpine would preferentially induce deficits in tasks involved with emotional contexts. Possible relationships with cognitive and emotional processing deficits in Parkinson disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579275     DOI: 10.1016/j.pnpbp.2008.05.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

1.  Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.

Authors:  Jennifer Ayers-Ringler; Jennifer S McDonald; Margaret A Connors; Cody R Fisher; Susie Han; Daniel R Jakaitis; Bradley Scherer; Gabriel Tutor; Katheryn M Wininger; Daying Dai; Doo-Sup Choi; Jeffrey L Salisbury; Paul J Jannetto; Joshua A Bornhorst; Ram Kadirvel; David F Kallmes; Robert J McDonald
Journal:  Radiology       Date:  2021-12-21       Impact factor: 11.105

2.  Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.

Authors:  Lucyna Antkiewicz-Michaluk; Agnieszka Wąsik; Edyta Możdżeń; Irena Romańska; Jerzy Michaluk
Journal:  Neurotox Res       Date:  2014-01-10       Impact factor: 3.911

3.  Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.

Authors:  Fernanda F Peres; Raquel Levin; Mayra A Suiama; Mariana C Diana; Douglas A Gouvêa; Valéria Almeida; Camila M Santos; Lisandro Lungato; Antônio W Zuardi; Jaime E C Hallak; José A Crippa; D'Almeida Vânia; Regina H Silva; Vanessa C Abílio
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

4.  Passiflora cincinnata Extract Delays the Development of Motor Signs and Prevents Dopaminergic Loss in a Mice Model of Parkinson's Disease.

Authors:  Luiz Eduardo Mateus Brandão; Diana Aline Morais Ferreira Nôga; Aline Lima Dierschnabel; Clarissa Loureiro das Chagas Campêlo; Ywlliane da Silva Rodrigues Meurer; Ramón Hypolito Lima; Rovena Clara Galvão Januário Engelberth; Jeferson Souza Cavalcante; Clésio Andrade Lima; Murilo Marchioro; Charles Dos Santos Estevam; José Ronaldo Santos; Regina Helena Silva; Alessandra Mussi Ribeiro
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-01       Impact factor: 2.629

5.  Si-Ni-San Prevents Reserpine-Induced Depression by Inhibiting Inflammation and Regulating CYP450 Enzymatic Activity.

Authors:  Yang Zong; Ting Chen; Hongli Dong; Lijing Zhu; Wenzheng Ju
Journal:  Front Pharmacol       Date:  2020-01-17       Impact factor: 5.810

6.  Vesicular monoamine transporter 2 mediates fear behavior in mice.

Authors:  Rachel C Branco; James P Burkett; Carlie A Black; Emily Winokur; William Ellsworth; Rohan K Dhamsania; Kelly M Lohr; Jason P Schroeder; David Weinshenker; Tanja Jovanovic; Gary W Miller
Journal:  Genes Brain Behav       Date:  2020-01-14       Impact factor: 3.449

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.